Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Lung Neoplasms 10Hemoptysis 3Pneumonia 2Lung Diseases 2Carcinoma, Non-Small-Cell Lung 2Tuberculosis 1Small Cell Lung Carcinoma 1Pulmonary Fibrosis 1Pulmonary Disease, Chronic Obstructive 1Neoplasms 1Lung Diseases, Obstructive 1Lung Diseases, Interstitial 1Laryngeal Neoplasms 1Disease 1Bronchitis 1Bronchiectasis 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms × Bronchoscopy × Clear all
NCT04770675 2022-05-03

Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.

Qmed Consulting A/S

Completed
833 enrolled

Hemoptysis, Lung Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡